Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
News
Two Life Sciences students have been recognised in this year’s Global Undergraduate Awards (UA). Nicole Coutinho Garrido was named as Regional Winner (Europe) while Dana Cheung was Highly Commended.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
Two sisters will make the University of Dundee’s Graduation celebrations a family affair this week.
Impact case study
Shaping the future of commercial drug development and driving global pharmaceutical investment.
Press release
The University of Dundee has been confirmed as one of the UK’s leading research centres for biological sciences, according to the results of the Research Excellence Framework (REF 2021)
Impact case study
Bringing about step-change in the diagnosis and treatment of neglected tropical diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Feature
Pawat Piyakitcharoen was one of the first students to study one of the new Life Sciences taught postgraduate courses. He explains how mixing science with business provided him with valuable knowledge and skills.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.